Farms.com Home   News

Intrauterine Vaccination of Sows and Gilts Offers Piglets Up-Front Disease Protection

An Associate Professor with the University of Saskatchewan’s College of Pharmacy and Nutrition says administration of vaccines to sows and gilts during artificial insemination offers their piglets earlier disease protection. Researchers with the Vaccine and Infectious Disease Organization and the College of Pharmacy and Nutrition at the University of Saskatchewan are evaluating the effectiveness of administering vaccines to sows and gilts along with sperm during artificial insemination to protect them and their offspring from diseases, focusing initially on Porcine Epidemic Diarrhea. Dr. Azita Haddadi, an Associate Professor with the Division of Pharmacy in the College of Pharmacy & Nutrition, says this approach offers a host of advantages.

Clip-Dr. Azita Haddadi-University of Saskatchewan:
First of all, it’s needle-free so that is one advantage. Then, in the pig industry, the majority of the commercial pigs are bred by artificial insemination so this vaccine is administered at the same time so you don’t need extra steps or extra procedures.
The other advantage is, because it’s in the uterus, it could cause some immunity in the mucus of the uterus that will better protect the fetus and, when the piglets are born, they’re already immunized. The first six weeks after the birth is the most challenging time for the piglets because their immune system is not fully developed yet and they have a higher chance of getting infected.
With this method when they’re born, they already have the immunization.

Click here to see more...

Trending Video

New Solution Powers Efficient Pork Growth

Video: New Solution Powers Efficient Pork Growth


Alltech has introduced Olerix, an innovative phytogenic blend created to promote growth and feed efficiency in pigs. Through a proprietary coating process, the bioactive blend of phytogenic compounds used in Olerix is designed to outlast the manufacturing process, ensuring consistent outcomes from feed to finish. The result is a high-impact efficiency solution that provides consistent support for gut health, feed efficiency, immune function and growth performance. Olerix is backed by validated trials conducted under modern pork production conditions.

“As the industry searches for technology to drive profitability forward in a more sustainable manner, we’re thrilled to join that effort with our Olerix technology,” said Mark Hulsebus, general manager for U.S. pork at Alltech. “Our work in this phytogenic space is yielding very encouraging results, and we’re excited to make this new opportunity available to pork producers focused on optimizing feed efficiency and growth rates.”

“Olerix represents the next generation of phytogenic technology — combining feed efficiency, livability and immune support into a practical commercial solution producers can implement today,” said Andy Rash, U.S. monogastric director at Alltech.